SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Abiomed Inc. – ‘8-K’ for 6/17/22 – ‘XML’

On:  Tuesday, 6/21/22, at 7:12am ET   ·   For:  6/17/22   ·   Accession #:  950170-22-11837   ·   File #:  1-09585

Previous ‘8-K’:  ‘8-K’ on / for 4/28/22   ·   Next:  ‘8-K’ on / for 8/4/22   ·   Latest:  ‘8-K’ on / for 12/22/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/21/22  Abiomed Inc.                      8-K:8       6/17/22   10:166K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
 5: R1          Document and Entity Information                     HTML     46K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- abmd-20220617_htm                   XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- abmd-20220617_lab                     XML     40K 
 4: EX-101.PRE  XBRL Presentations -- abmd-20220617_pre              XML     33K 
 2: EX-101.SCH  XBRL Schema -- abmd-20220617                         XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
10: ZIP         XBRL Zipped Folder -- 0000950170-22-011837-xbrl      Zip     12K 


‘XML’   —   XBRL Instance — abmd-20220617_htm


This Document is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="abmd-20220617.xsd" xlink:type="simple"/>
<context id="C_924efc34-3b58-4738-bc49-b20b8107bba2">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0000815094 </identifier>
</entity>
<period>
<startDate> 2022-06-17 </startDate>
<endDate> 2022-06-17 </endDate>
</period>
</context>
<dei:EntityCentralIndexKey contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_0960b92b-3f87-4f2f-9d90-af58b7af91a8"> 0000815094 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_3e493e5f-836b-4c9c-a970-d36f736343dd"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_96313927-dd0a-4ad1-b3be-cfe047ee5b54"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_7590ff3e-6952-4777-9225-dbe556bc1461"> 2022-06-17 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_a3166572-3975-4ec0-8a74-e3b371167dfe"> ABIOMED, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_a1ae8634-be6f-4a14-8de1-899491bca46c"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_0c181bcc-18a2-4a5a-b381-38f7e56d05ab"> 001-09585 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_739d754f-eceb-4b84-82df-66b434a596ae"> 04-2743260 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_49441e5a-6006-4c0c-bdf5-43b4017c6514"> 22 Cherry Hill Drive </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_f64f9fb3-600d-4dae-b90f-7cfd9e556273"> Danvers </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_1f5b88b2-16b9-453e-91b4-de7611bcb390"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_061cd836-f328-4ed6-9dd1-3d411805faef"> 01923 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_fe6c3fcc-cf51-4d88-a444-80b362ce1197"> 978 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_3a9c71fd-0da2-4839-b8be-57d67f772b41"> 646-1400 </dei:LocalPhoneNumber>
<dei:Security12bTitle contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_18f1b9fd-abff-4009-8ed6-67a28dd1b3e5"> Common Stock, $0.01 par value </dei:Security12bTitle>
<dei:TradingSymbol contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_cc83e473-e1e9-47ef-966d-cde7e31000ce"> ABMD </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_b7dc7ba6-2c54-4567-b474-6e137a3961d3"> NASDAQ </dei:SecurityExchangeName>
<dei:WrittenCommunications contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_770836f7-b30c-4ad4-9a1d-13c58ae276a3"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_4235caab-6e09-4b6d-a817-8c9bb50827cc"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_a26f81c5-a71c-421c-99c5-c1e5815d533c"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_e9fa7370-5d2b-4775-982d-3272810ddee6"> false </dei:PreCommencementIssuerTenderOffer>
<dei:EntityEmergingGrowthCompany contextRef="C_924efc34-3b58-4738-bc49-b20b8107bba2" id="F_fa8ce1e9-3ad2-4323-9e54-140f7e03e542"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

Top
Filing Submission 0000950170-22-011837   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 1:27:23.1am ET